ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,463Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 343

$1.26M Total Retail Price of All Prescriptions

Rank: 21 out of 343

734 Patients Receiving at Least One Drug in Part D
64% Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Mississippi
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

15% of this provider’s 734 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

44% of this provider’s 734 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 2,317 1,102 314 S3 1 2
AMLODIPINE BESYLATE 1,121 789 169 2 1
OMEPRAZOLE 896 593 143 3 3
LEVOTHYROXINE SODIUM 771 608 109 4 5
FUROSEMIDE 699 470 152 5 4
ALPRAZOLAM 617 249 96 B 6 20
LISINOPRIL 602 385 104 7 6
MELOXICAM 518 305 103 8 21
ENALAPRIL MALEATE 450 256 72 9 67
PRAVASTATIN SODIUM 418 281 68 10 11
GABAPENTIN 403 236 76 11 12
METOPROLOL SUCCINATE 399 256 58 12 16
TEMAZEPAM 379 212 73 B 13 82
ATENOLOL 371 209 50 14 30
SIMVASTATIN 367 293 54 15 7
POTASSIUM CHLORIDE 366 261 75 16 10
OXYCODONE HCL 366 76 45 S2 16 201
DIAZEPAM 361 92 48 B 18 93
METFORMIN HCL 353 189 56 19 9
DIOVAN 348 260 52 20 35
LOSARTAN POTASSIUM 346 239 54 21 19
ZOLPIDEM TARTRATE 338 123 60 22 24
ATORVASTATIN CALCIUM 325 223 61 23 8
CITALOPRAM HBR 300 197 39 24 23
METOPROLOL TARTRATE 297 189 45 25 17
CLOPIDOGREL 296 238 46 26 15
TIZANIDINE HCL 278 107 59 27 77
CARISOPRODOL 257 33 28 R 28 79
CARVEDILOL 250 186 40 29 13
LORAZEPAM 245 174 45 B 30 51
HYDROCHLOROTHIAZIDE 232 152 40 31 14
SERTRALINE HCL 232 127 41 31 33
PAROXETINE HCL 226 111 33 33 73
CLONAZEPAM 219 94 36 B 34 48
KLOR-CON 10 204 154 39 35 88
OXYCODONE HCL-ACETAMINOPHEN 199 97 46 S2 36 99
NEXIUM 197 126 31 37 26
PANTOPRAZOLE SODIUM 194 129 40 38 32
BENAZEPRIL HCL 184 143 23 39 64
FAMOTIDINE* 179 114 36 40 72
AMITRIPTYLINE HCL 175 108 28 R 41 56
LYRICA 175 63 27 41 61
ISOSORBIDE MONONITRATE ER 171 141 30 43 54
CRESTOR 165 104 32 44 29
RANITIDINE HCL 162 81 27 45 38
CYMBALTA 156 25 21 46 44
TAMSULOSIN HCL 156 113 26 46 37
ALLOPURINOL 154 119 23 48 31
GLIPIZIDE ER 150 88 20 49 102
WARFARIN SODIUM 149 84 36 50 18
TRAMADOL HCL 148 94 32 51 22
FENTANYL 136 90 21 S2 52 119
PROAIR HFA 134 60 38 53 60
METFORMIN HCL ER 131 73 22 54 58
LANTUS 129 79 23 55 69
VALSARTAN-HYDROCHLOROTHIAZIDE 127 100 20 56 52
GLIPIZIDE 127 68 21 56 70
CYCLOBENZAPRINE HCL 126 33 33 R 58 75
SYNTHROID 122 75 22 59 50
TRAZODONE HCL 121 47 21 60 45
AMLODIPINE BESYLATE-BENAZEPRIL 121 62 18 60 59
SPIRONOLACTONE 121 37 14 60 42
CELEBREX 117 99 21 63 98
ESCITALOPRAM OXALATE 114 49 26 64 46
DONEPEZIL HCL 112 112 17 65 28
MONTELUKAST SODIUM 109 68 18 66 43
FENOFIBRATE* 107 59 15 67 66
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 54 73 68 92
POLYETHYLENE GLYCOL 3350 102 57 23 69 74
ZETIA 97 67 12 70 71
ROPINIROLE HCL 97 58 20 70 95
CEFUROXIME 95 56 78 72 130
AZITHROMYCIN 93 48 73 73 65
MECLIZINE HCL 90 62 30 74 91
NAMENDA 90 90 15 74 34
ADVAIR DISKUS 86 52 16 76 85
DOXAZOSIN MESYLATE 85 63 15 77 90
NITROSTAT 85 56 26 77 190
PREDNISONE 84 47 25 79 53
CLONIDINE HCL 84 42 16 79 36
BACLOFEN 84 34 13 79 141
AMIODARONE HCL 81 76* 18 82 113
NAPROXEN 80 41 17 83 84
DILTIAZEM ER 79 59 11 84 188
LEVEMIR FLEXPEN 77 38 14 85 125
FLUCONAZOLE 75 39 51 86 137
SUCRALFATE 74 43 15 87 177
PIOGLITAZONE HCL 74 <11 <11 R 87 100
GLIPIZIDE XL 74 38 12 87 166
ONDANSETRON HCL* 73 48 26 90 222
OXYBUTYNIN CHLORIDE 71 59 12 91 153
FLUTICASONE PROPIONATE 70 49 31 92 47
GLIMEPIRIDE 69 42 13 93 27
ENDOCET 69 28 28 S2 93 236
TERAZOSIN HCL 68 <11 <11 95 154
METHADONE HCL 67 <11 <11 S2 96 260
JANUVIA 65 33 12 97 62
DILTIAZEM 24HR CD 62 <11 <11 98 174
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 <11 <11 99 25
HUMULIN N 57 22 12 100 227
PROMETHAZINE HCL 57 17 21 R 100 108
SOTALOL 57 <11 <11 100 221
DIGOXIN 56 <11 <11 103 158
EXFORGE 56 <11 <11 103 134
VENLAFAXINE HCL ER 54 <11 <11 105 94
GEMFIBROZIL 53 <11 <11 106 123
MUPIROCIN* 53 17 28 106 216
FLUOXETINE HCL 53 <11 <11 106 81
MEGESTROL ACETATE 52 52 12 R 109 122
BYSTOLIC 51 <11 <11 110 78
LANTUS SOLOSTAR 51 46* 12 110 101
METOLAZONE 51 35 18 110 169
SPIRIVA 51 25 13 110 87
METHYLPREDNISOLONE 50 30 37 114 105
LOSARTAN-HYDROCHLOROTHIAZIDE 50 <11 <11 114 40
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.